trimethylamine has been researched along with 2019 Novel Coronavirus Disease in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 2 (100.00) | 2.80 |
Authors | Studies |
---|---|
Chiang, EI | 1 |
Syu, JN | 1 |
Hung, HC | 1 |
Rodriguez, RL | 1 |
Wang, WJ | 1 |
Chiang, ER | 1 |
Chiu, SC | 1 |
Chao, CY | 1 |
Tang, FY | 1 |
Alexander, JL | 1 |
Mullish, BH | 1 |
Danckert, NP | 1 |
Liu, Z | 1 |
Olbei, ML | 1 |
Saifuddin, A | 1 |
Torkizadeh, M | 1 |
Ibraheim, H | 1 |
Blanco, JM | 1 |
Roberts, LA | 1 |
Bewshea, CM | 1 |
Nice, R | 1 |
Lin, S | 1 |
Prabhudev, H | 1 |
Sands, C | 1 |
Horneffer-van der Sluis, V | 1 |
Lewis, M | 1 |
Sebastian, S | 1 |
Lees, CW | 1 |
Teare, JP | 1 |
Hart, A | 1 |
Goodhand, JR | 1 |
Kennedy, NA | 1 |
Korcsmaros, T | 1 |
Marchesi, JR | 1 |
Ahmad, T | 1 |
Powell, N | 1 |
2 other studies available for trimethylamine and 2019 Novel Coronavirus Disease
Article | Year |
---|---|
N-3 polyunsaturated fatty acids block the trimethylamine-N-oxide- ACE2- TMPRSS2 cascade to inhibit the infection of human endothelial progenitor cells by SARS-CoV-2.
Topics: Angiotensin-Converting Enzyme 2; COVID-19; Docosahexaenoic Acids; Eicosapentaenoic Acid; Endothelial | 2022 |
The gut microbiota and metabolome are associated with diminished COVID-19 vaccine-induced antibody responses in immunosuppressed inflammatory bowel disease patients.
Topics: Antibody Formation; BNT162 Vaccine; ChAdOx1 nCoV-19; COVID-19; COVID-19 Vaccines; Gastrointestinal M | 2023 |